A Rare Association of Hypomagnesemia and Posterior Reversible Encephalopathy Syndrome (PRES).
diarrhea
hypomagnesemia
posterior reversible encephalopathy syndrome
posterior reversible encephalopathy syndrome (pres)
pres syndrome
reversible posterior leukoencephalopathy syndrome (rpls)
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
accepted:
08
07
2023
medline:
9
8
2023
pubmed:
9
8
2023
entrez:
9
8
2023
Statut:
epublish
Résumé
Posterior reversible encephalopathy syndrome (PRES) is a rare neurologic disorder that presents with variable symptoms and symmetrical abnormal white matter signaling most commonly of the occipital and parietal lobes on magnetic resonance imaging (MRI). PRES, also known as reversible posterior leukoencephalopathy syndrome (RPLS) is commonly associated with hypertension. Hypomagnesemia's association with PRES has been rarely reported. Here, we report a patient with severe hypomagnesemia that presented with PRES syndrome that improved with magnesium replacement. Hypomagnesemia should be considered an underlying etiology in patients presenting with PRES syndrome and should be promptly treated. The presentation can often be concerning for acute cerebrovascular accidents with symptoms of dysarthria and upper motor neuron symptoms, such as facial droop, dysarthria, and gait instability. Differential diagnosis of PRES often includes rostral brainstem infarction, transient ischemic attack, infectious encephalopathy, and metabolic/toxic encephalopathy, which is evaluated in the description of the case. The most common presentation of RPLS/PRES includes altered mental status, drowsiness, seizure, vomiting, alterations in speech including dysarthria, and visual disturbance. The first signs noted are commonly lethargy and somnolence. In this case, the patient presented notably with initial symptoms of dysarthria of speech and facial droop, with serum hypomagnesemia in which symptoms corrected rapidly with the administration of intravenous magnesium sulfate.
Identifiants
pubmed: 37554607
doi: 10.7759/cureus.41572
pmc: PMC10406392
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e41572Informations de copyright
Copyright © 2023, Ball et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):384-8
pubmed: 27371132
Oxf Med Case Reports. 2017 Apr 03;2017(4):omx011
pubmed: 28473920
Acta Biomed. 2020 May 11;91(2):365-372
pubmed: 32420975
Lancet Neurol. 2015 Sep;14(9):914-925
pubmed: 26184985
Cerebellum. 2014 Oct;13(5):659-62
pubmed: 24838431
Clin Neuroradiol. 2015 Jun;25(2):161-71
pubmed: 24554281
Neurologist. 2018 Mar;23(2):65-66
pubmed: 29494439
Seizure. 2020 Jan 7;76:12-16
pubmed: 31945641
Case Rep Med. 2018 Nov 29;2018:1980638
pubmed: 30631367
J Neurol Sci. 2019 Sep 15;404:72-79
pubmed: 31349066
J Hypertens. 2000 Sep;18(9):1177-91
pubmed: 10994748
Pract Neurol. 2018 Aug;18(4):311-314
pubmed: 29449419
AJNR Am J Neuroradiol. 2007 Aug;28(7):1320-7
pubmed: 17698535
Case Rep Neurol. 2021 Oct 22;13(3):693-698
pubmed: 34899254
Can Assoc Radiol J. 2017 May;68(2):147-153
pubmed: 28131335